Shikonin triggered dose-dependent apoptosis in cancer cells by raising intracellular levels of reactive oxygen species (ROS), which are primarily formed by lipoxygenase, NADPH oxidase, and mitochondrial complex II (Zhao et al., 2022). This evidence concerns the gene FMO5 and cancer.